FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Strides Pharma Benzonatate capsules Recall

Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasu…

Strides Pharma INC · East Brunswick, NJ

Risk level
Class III
Reported by FDA
May 31, 2017
Recall ID
D-0858-2017
Check your lot numberHow we source this data

Summary

Strides Pharma recalled Benzonatate capsules starting May 9, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0858-2017 on May 31, 2017. Reason: Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content. Status: Terminated.

Why it was recalled

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Product description

Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06

Lot numbers, UPCs & expiration codes

Lot #: 7225075, 7225076, 7225077, 7225078, 7225079, 7225080 Exp 7/2017; 7225180, 7225181, 7225322, 7225323, Exp 8/2017; 7225649A, 7225650A , 7225651A , 7225652A, 7225653A, 7225654A, Exp 9/2017

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0858-2017
Classification
Class III
Status
Terminated
Recall initiated
May 9, 2017
FDA report date
May 31, 2017
Quantity
127,517 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Strides Pharma INC

Original FDA data

Every field from FDA enforcement report D-0858-2017, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
77311
Address
2 Tower Center Blvd Ste 1102
Code information
Lot #: 7225075, 7225076, 7225077, 7225078, 7225079, 7225080 Exp 7/2017; 7225180, 7225181, 7225322, 7225323, Exp 8/2017; 7225649A, 7225650A , 7225651A , 7225652A, 7225653A, 7225654A, Exp 9/2017
Postal code
08816-1100
Report date
May 31, 2017
Product type
Drugs
Recall number
D-0858-2017
Classification
Class III
Recalling firm
Strides Pharma INC
Product quantity
127,517 bottles
Termination date
Dec 22, 2017
Reason for recall
Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06
Distribution pattern
U.S.A. Nationwide
Recall initiation date
May 9, 2017
Initial firm notification
Letter
Center classification date
May 23, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0858-2017, published May 31, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls